SCHEMBL82369

SCHEMBL82369

[O]c1c2ccccc2cc2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.52
HSD17B10 Q99714 4/20 0.52
CYP1A2 P05177 4/20 0.52
KDM4E B2RXH2 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
HPGD P15428 2/20 0.52
GLA P06280 1/20 0.52
CYP2C19 P33261 1/20 0.52
CYP3A4 P08684 1/20 0.50
HIF1A Q16665 1/20 0.50
CYP1B1 Q16678 1/20 0.50
HTR2A P28223 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP2A6 P11509 2/20 0.45
TSHR P16473 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
ERBB2 P04626 1/20 0.44
FYN P06241 1/20 0.44
MAOA P21397 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrogen Sulfide SCHEMBL27992662 0.97 ALDH1A1 (0.50) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL11973762 0.90 ALDH1A1 (0.48) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
Anthraquinone SCHEMBL1376042 0.77 ALDH1A1 (0.41) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL294408 0.76 CYP1A2 (0.48) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL7306166 0.76 ALDH1A1 (0.43) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL5609984 0.76 HPRT1 (0.41) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL7305590 0.76 TRPM4 (0.56) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL149754 0.75 ALDH1A1 (0.55) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
Triphenylene SCHEMBL28075721 0.74 HPRT1 (0.59) ALDH1A1HSD17B10CYP1A2KDM4EMEN1
SCHEMBL28383579 0.73 ALDH1A1 (0.52) ALDH1A1HSD17B10CYP1A2KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1656 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339973-A1 RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA QURETECH BIO AB (SE) 2023-10-26 US claimed
US-20230233536-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA QURETECH BIO AB (SE) 2023-07-27 US claimed
EP-4146659-A1 RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA Quretech Bio AB (SE) 2023-03-15 EP claimed
CN-115551869-A Fused ring 2-pyridone compounds, process for their preparation and their use for the treatment and/or prevention of diseases involving gram-positive bacteria 快尔生物技术公司 2022-12-30 CN claimed
US-20210401815-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA WASHINGTON UNIVERSITY 2021-12-30 US claimed
WO-2021224501-A1 RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA QURETECH BIO AB (SE) 2021-11-11 WO claimed
CN-113024587-A Condensed aromatic derivative containing boron and nitrogen, method for preparing same, and organic electroluminescent device 吉林奥来德光电材料股份有限公司 2021-06-25 CN claimed
EP-3638681-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA Quretech Bio AB (SE) 2020-04-22 EP claimed
CN-110799513-A Ring-fused thiazolo-2-pyridones, method for the production thereof and use thereof for treating and/or preventing diseases which involve gram-positive bacteria 快尔生物技术公司 2020-02-14 CN claimed
WO-2018229141-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA QURETECH BIO AB (SE) 2018-12-20 WO claimed
US-20020034657-A1 Organic electroluminescence device NEC CORPORATION. 2002-03-21 US claimed
EP-0231497-A1 Silicone resist materials containing polysiloxanes KABUSHIKI KAISHA TOSHIBA (JP) 1987-08-12 EP claimed
US-12043749-B2 Method for producing ink composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2024-07-23 US disclosed
US-12043627-B2 Compound and color conversion film comprising same LG CHEM, LTD. (KR) 2024-07-23 US disclosed
EP-4400526-A1 POLYMER AND ORGANIC LIGHT-EMITTING DEVICE USING SAME LG Chem, Ltd. (KR) 2024-07-17 EP disclosed
WO-2024147631-A1 POLYCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE USING SAME 에스에프씨 주식회사 2024-07-11 WO disclosed
US-4792551-A 9-anthryloxyaminoalkanes and related compounds as anti-inflammatory and analgetic agents SYNTEX (U.S.A.) INC. (US) 1988-12-20 US disclosed
EP-0231497-A1 Silicone resist materials containing polysiloxanes KABUSHIKI KAISHA TOSHIBA (JP) 1987-08-12 EP disclosed
EP-0132351-A2 9-Anthryloxyaminoalkanes and related compounds, processes for their preparation and pharmaceutical compositions containing them SYNTEX (U.S.A.) INC. (US) 1985-01-30 EP disclosed
EP-0045431-A1 Process for the side-chain bromination of toluenes and mixtures of toluenes diversly highly brominated in the side chain BAYER AG (DE) 1982-02-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210401815-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA TLR4, NOD2, TLR5 ALDH1A1 2426/4885HSD17B10 676/4885CYP1A2 2058/4885
US-20230339973-A1 RING-FUSED 2-PYRIDONE COMPOUNDS, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA PGLS, BLVRB, SDHB ALDH1A1 2766/4885HSD17B10 575/4885CYP1A2 1097/4885
US-20230233536-A1 RING-FUSED THIAZOLINO 2-PYRIDONES, METHODS FOR PREPARATION THEREOF AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF A DISEASE INVOLVING GRAM-POSITIVE BACTERIA NOD2, TLR4, TLR5 ALDH1A1 2321/4885HSD17B10 481/4885CYP1A2 2164/4885
US-12043627-B2 Compound and color conversion film comprising same CRY1, FLI1, FDFT1 ALDH1A1 47/4885HSD17B10 693/4885CYP1A2 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.